科研课题（Fundings）：
1.国自然面上项目（82472693），主持，2025-2028；
National Natural Science Foundation of China（82472693）,PI,2025-2018;
2.国自然青年项目（82003080），主持，2021-2023；
National Natural Science Foundation of China（82003080）,PI,2021-2023；
3.上海市科委扬帆英才计划（20YF1453300），主持，2020-2023；
The Shanghai Youth Elite Sailing Program（20YF1453300）,PI,2020-2023；
4.上海市浦东新区卫生系统优秀青年医学人才培养计划（PWRq2024-01），主持，2025-2027；
Training Program for Outstanding Young Medical Talents in the Health System of Pudong New Area（PWRq2024-01）,PI,2025-2027；
5.美高梅“中央高校基本科研业务费”专项资金（22120240330），主持，2024-2026；
Tongji University-the Fundamental Research Funds for the Central Universities（22120240330）,PI, 2024-2026；
6.中国临床肿瘤学会-朝阳基金（Y-Young2024-0323），主持，2025-2026；
CSCO-Clinical Oncology Research Foundation（Y-Young2024-0323）,PI,2025-2026
荣誉奖项（Awards）：
1.上海市浦东新区卫生健康青年优秀人才（2023，B类）
2.中国临床肿瘤学会CSCO -“35 under 35”优秀青年肿瘤医生 (2023)
3.韩国临床肿瘤学会KSMO - Young Investigator Award (韩国, 2023)
4.上海市扬帆英才(2020)
5.美国癌症研究协会AACR–GYRIG (Get Your Rear In Gear) Scholar-in-Training Award (美国,2017)
6.UNMC Bernice and Norman Harris Excellence Award (美国, 2018)
7.UNMC Graduate Student Fellowship (美国 , 2017-2018，2018-2019)
8.上海市优秀毕业生 (2015)
9.宝钢教育奖(2015)
研究论文（Publications）：
1.Jiuli Zhou, Yongji Zeng, Lian Cui, Xingcheng Chen, Seth Stauffer, Zhan Wang, Fang Yu, Subodh M. Lele, Adrian Black, Yuanhong Chen and Jixin Dong*. Zyxin promotes colon cancer tumorigenesis in a mitotic phosphorylation-dependent manner and through CDK8-mediated YAP activation. PNAS., 2018. 115(29): p. E6760-E6769.
2. Jiuli Zhou#, Lin Zhang#, Wei Zhou, Yuanhong Chen, Yufeng Cheng* and Jixin Dong*. LIMD1 phosphorylation in mitosis is required for mitotic progression and its tumor-suppressing activity. FEBS J.，2019. 286（5）：p.963-974.
3. Xu, X., X. Duan, S. Wang, Y. Zhang, Y. Gao, X. Xu, G. Yeerkenbieke, J. Zhou*, and J. Li*. Discoidin domain receptor 2 promotes colorectal cancer metastasis by regulating epithelial mesenchymal transition via activating AKT signaling. Int J Cancer, 2022.
4. Duan, X., X. Xu, Y. Zhang, Y. Gao, J. Zhou*, and J. Li*. DDR1 functions as an immune negative factor in colorectal cancer by regulating tumor-infiltrating T cells through IL-18. Cancer Sci, 2022.
5.Yongji Zeng; Ling Yin; Jiuli Zhou ; Renya Zeng; Yi Xiao; Adrian R Black; Tuo Hu; Pankaj Singh; Feng Yin; Surinder K. Batra; Fang Yu; Yuanhong Chen; Jixin Dong* ; MARK2 regulates chemotherapeutic responses through class IIa HDAC-YAP axis in pancreatic cancer, Oncogene, 2022,41(31): 3859-3875
6.Liqiong Xue#; Wenbo Tang#; Jiuli Zhou#; Junli Xue; Qun Li; Xiaoxiao Ge; Fengjuan Lin; Wei Zhao; Ye Guo* ; Next-generation sequencing identifies CDKN2A alterations as prognostic biomarkers in recurrent or metastatic head and neck squamous cell carcinoma predominantly receiving immune checkpoint inhibitors, Frontiers in oncology, 2023, 13(1276009)
